INTRODUCTION: @entity117 induced @entity565 (AIA) is a syndrome, with typical clinical features. @entity117 and Nsaids induced @entity565 is its distinctive characteristic. OBJECTIVE: Was to determine challenge and bronchodilator test usefulness, as well as its complications, in @entity1 with @entity117 induced @entity565 . MATERIAL AND METHODS: Prospective, open, transversal and comparative study of 20 @entity1 divided in two groups of ten @entity1 each one group with an @entity117 induced @entity565 antecedent, undertook a challenge and bronchodilator test, and the second group was composed of @entity1 with @entity565 which were exposed to a challenge test. All @entity1 had a physical exam and laboratory test, besides paranasal and chest X-ray, @entity56 skin test and spirometry. Criteria used to make diagnosis of AIA were defined as a 15% decrease of FEV-1 in the both groups. Laboratory and other paraclinic studies were made in order to assess diagnosis and/or complications. RESULTS: In the first group it was observed a 15% statistically significant decrease of FEV-1 and FEF 25-75 values (p < 0.05), on second group an statistically significant increase in FEV-1 values of more than 15% was observed in 7 @entity1 (p < 0.05). In the control group no statistically significative changes were observed in the @entity1 . The more frequent complications after challenge test were wheeze, @entity1353 , cough and severe @entity5143 . Zero defunctions were reported. CONCLUSION: The minimum dose to realize the diagnosis of AIA are 100 mg of @entity117 . The FEV-1 decrease depend of dose of @entity117 in @entity1 with AIA. @entity1 with @entity565 without an @entity117 intolerance history, have non adverse effects with @entity117 ingestion. Severe @entity5143 was the most severe complication in @entity1 who underwent @entity117 challenge test who had an idiosyncrasy history.

[Respiratory function tests in XXXX -induced @entity565 ].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'people'] @entity1353 :: ('MESH:D004417', 'Disease') :: ['dyspnea'] @entity565 :: ('MESH:D001249', 'Disease') :: ['Asthma', 'extrinsic asthma'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['Aspirin', 'aspirin'] @entity56 :: ('MESH:D004342', 'Disease') :: ['allergic'] @entity5143 :: ('MESH:D001986', 'Disease') :: ['bronchospasm']
@entity117 :: (MESH:D001241,Chemical) :: ['aspirin']
